Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction

This publication has 9 references indexed in Scilit:

• The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
  Clinical Drug Investigation, 2021
• Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists
  Journal of Addiction Medicine, 2021
• Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial
  Addiction Science & Clinical Practice, 2021
• Microinduction of Buprenorphine/Naloxone: A Review of the Literature
  The American Journal on Addictions, 2020
• Hospital-based Buprenorphine Micro-dose Initiation
  Journal of Addiction Medicine, 2020
• Protracted renal clearance of fentanyl in persons with opioid use disorder
  Drug and Alcohol Dependence, 2020
• Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market
  Canadian Medical Association Journal, 2020
• Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting
  Journal of Addiction Medicine, 2020
• Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method”
  Substance Abuse and Rehabilitation, 2016